{"id":"8cb98a0f-8d18-4c55-9089-3583140a8e93","kind":"news","code":"8cb98a0f-8d18-4c55-9089-3583140a8e93","name":"Respiree raises USD 11.6 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Respiree完成1160万美元A轮融资","eventDate":"2025-07-23T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:23.341Z","englishUpdatedAt":"2026-10-15T17:19:59.725Z","reviewedAt":"2026-10-15T17:19:59.725Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a71ed39c158847830a3d13b361cadda8bde5e64e25b8c10588ab6e5a96456a2","companyId":"00e4ddf5-62a7-4779-99c5-1e735b998a7b","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"4465e5af-fab3-4d4d-a70c-eb787516d0b4","kind":"institutions","code":"UB-I6168","name":"Adaptive Capital Partners","nameBasis":"original-brand","summary":"Adaptive Capital Partners","description":"Adaptive Capital Partners","country":"United States","category":null,"originalName":"Adaptive Capital Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T02:00:23.233Z","englishUpdatedAt":"2026-10-20T18:26:50.009Z","reviewedAt":"2026-10-20T18:26:50.009Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"f60acafe83270f51ec346af964088895b06706e36f7e5d99ff9474e195e889dc","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/adaptive-capital-partners"},{"id":"61ad6da4-b5f2-4685-b29c-01afc40af83e","kind":"institutions","code":"UB-I6262","name":"ClavystBio","nameBasis":"original-brand","summary":"ClavystBio is a life sciences venture capital firm.","description":"ClavystBio is a life sciences venture capital firm.","country":"Singapore","category":null,"originalName":"ClavystBio","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T02:00:24.047Z","englishUpdatedAt":"2026-10-20T18:26:56.465Z","reviewedAt":"2026-10-20T18:26:56.465Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"673ed343a087a5d148dfdc0bb4b087b8144dc0d4dba06f4d1a1ecfd62c805274","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/clavystbio"},{"id":"00e4ddf5-62a7-4779-99c5-1e735b998a7b","kind":"companies","code":"UB-C6192","name":"Respiree","nameBasis":"source-english","summary":"Platform for disease progression monitoring, cardiopulmonary health AI and wearable healthcare.","description":"","country":"United States","category":null,"originalName":"Respiree","eventDate":null,"website":"https://www.respiree.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:21:34.721Z","reviewedAt":"2026-10-20T18:21:34.721Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"9da3a52418ecbf9a0fb242bb6811441297a11b81ddefdb53c0c2ec54e7652c12","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/respiree"},{"id":"200da8ba-0e13-4136-b6cc-8ba6c97332e4","kind":"institutions","code":"UB-I6195","name":"We Venture Capital","nameBasis":"original-brand","summary":"We Venture Capital","description":"We Venture Capital","country":"United States","category":null,"originalName":"We Venture Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T02:00:23.512Z","englishUpdatedAt":"2026-10-20T18:26:49.508Z","reviewedAt":"2026-10-20T18:26:49.508Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8517ca9d3a2721afc6b319ea32dc1a72b6b9917a26893dc11d8aee79a9aca60d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/we-venture-capital"}],"path":"/news/8cb98a0f-8d18-4c55-9089-3583140a8e93","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Respiree","path":"/companies/respiree"}},"canonical":"https://uniquebase.ai/news/8cb98a0f-8d18-4c55-9089-3583140a8e93"}